SHAGORY PETER K 4

4 · CONMED CORP · Filed Oct 30, 2020

Form 4

Period: 2020-10-30

EVP, STRAT & CORP DEVT

Transactions

Other
Options To Purchase Common Stock
2020-10-30−1,998→ 2,442 total
Exercise: $39.87Exp: 2026-03-01→ Common Stock (1,998 underlying)
Other
Options To Purchase Common Stock
2020-10-30−8,050→ 14,950 total
Exercise: $97.69Exp: 2030-03-02→ Common Stock (8,050 underlying)
Other
Options To Purchase Common Stock
2020-10-30−8,865→ 9,435 total
Exercise: $41.93Exp: 2027-03-01→ Common Stock (8,865 underlying)
Other
Sars (Stock Appreciation Rights)
2020-10-30$55.42/sh−11,000$609,620→ 9,000 total
Exercise: $55.42Exp: 2025-05-11→ Common Stock (11,000 underlying)
Other
Options To Purchase Common Stock
2020-10-30−9,840→ 14,160 total
Exercise: $78.76Exp: 2029-03-01→ Common Stock (9,840 underlying)
Other
Options To Purchase Common Stock
2020-10-30−11,960→ 14,040 total
Exercise: $59.96Exp: 2028-03-01→ Common Stock (11,960 underlying)

Footnotes (5)

[F1]Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee.
[F2]The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
[F3]The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
[F4]The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
[F5]The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Documents

1 file